Silvant Capital Management LLC Has $39.75 Million Position in Intuitive Surgical, Inc. $ISRG

Silvant Capital Management LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 88,875 shares of the medical equipment provider’s stock after buying an additional 2,046 shares during the period. Intuitive Surgical comprises approximately 1.4% of Silvant Capital Management LLC’s portfolio, making the stock its 16th biggest position. Silvant Capital Management LLC’s holdings in Intuitive Surgical were worth $39,748,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of ISRG. Vanguard Group Inc. lifted its stake in Intuitive Surgical by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after acquiring an additional 263,828 shares in the last quarter. State Street Corp boosted its position in Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after acquiring an additional 182,871 shares during the period. Geode Capital Management LLC grew its stake in Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after acquiring an additional 109,904 shares in the last quarter. Capital World Investors increased its holdings in shares of Intuitive Surgical by 1.5% in the 3rd quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock valued at $3,456,223,000 after purchasing an additional 116,034 shares during the period. Finally, Norges Bank acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $2,569,260,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. BTIG Research restated a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a report on Friday, January 23rd. Sanford C. Bernstein increased their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 19th. UBS Group set a $570.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Tuesday, February 24th. Finally, Royal Bank Of Canada lifted their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $615.86.

Intuitive Surgical Trading Down 1.6%

Shares of NASDAQ:ISRG opened at $485.85 on Wednesday. The stock has a market capitalization of $172.54 billion, a PE ratio of 61.58, a P/E/G ratio of 3.81 and a beta of 1.66. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $603.88. The firm has a fifty day moving average price of $518.26 and a 200 day moving average price of $512.74.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period last year, the company earned $2.21 earnings per share. The business’s revenue was up 18.8% compared to the same quarter last year. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the transaction, the senior vice president owned 907 shares of the company’s stock, valued at $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the sale, the executive vice president owned 409 shares of the company’s stock, valued at $202,438.64. The trade was a 50.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 37,802 shares of company stock valued at $19,945,322. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.